Squamous cell carcinoma in solid organ transplant recipients: Review of the literature

Jul 8, 2024 | Magazine: Medicina Clínica

Inés Oteiza Rius 1 , Ana Morelló Vicente 2 , Leyre Aguado Gil 1

Abstract

Solid organ transplant recipients (SOTRs) exhibit an elevated incidence and aggressiveness of squamous cell carcinomas (SCCs) due to their immunosuppression. These tumors are associated with a heightened risk of metastasis and increased mortality. Therefore, an appropriate management of these patients is essential to improve their prognosis.

Given the scarcity of studies on non-melanoma skin cancers (NMSCs) in SOTRs, this article aims to summarize and analyze the evidence gathered to date regarding therapeutic approaches, personalized monitoring, and prevention strategies for SCCs in these patients. Additionally, recent advancements in understanding SCCs within this patient group are also documented.

CITATION Med Clin (Barc). 2024 Jul 8:S0025-7753(24)00370-1. doi: 10.1016/j.medcli.2024.05.005

see publication in pubmed

Our authors

Imagen de la Dra. Leire Aguado Gil, especialista en Dermatología Médico Quirúrgica y Venereológica de la Clínica Universidad de Navarra. La Dra. Aguado se dedica preferencialmente al estudio y tratamiento del vitíligo.

Dr. Leyre Aguado Gil [SP] Curriculum

Specialist Dermatology Department

Navarre headquarters